Olema Pharmaceuticals Inc
OLMA
Market Cap$316.11M
Close$
$2.35
48.6% downside
Current Fair Value
48.6% downsideOvervalued by 48.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $316.11 Million |
|---|---|
| Enterprise Value | $243.35 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-2.2 |
| Beta | 2.01 |
| Outstanding Shares | 85,426,223 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -3.06 |
|---|---|
| PEG | 163.22 |
| Price to Sales | - |
| Price to Book Ratio | 1.14 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -1.7 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | -0.09 |
| Debt to Equity | -0.06 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Olema Pharmaceuticals Inc
37 employeesOlema Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of targeted therapies for women’s cancers. Its lead product candidate, OP-1250, is an o...